BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 36655868)

  • 1. The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.
    Miao B; Bauer AS; Hufnagel K; Wu Y; Trajkovic-Arsic M; Pirona AC; Giese N; Taipale J; Siveke JT; Hoheisel JD; Lueong S
    Int J Cancer; 2020 Jul; 147(1):189-201. PubMed ID: 31846072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter.
    Ren G; Li H; Hong D; Hu F; Jin R; Wu S; Sun W; Jin H; Zhao L; Zhang X; Liu D; Huang C; Huang H
    BMC Cancer; 2023 Sep; 23(1):898. PubMed ID: 37742010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between DNA methyltransferase 3B (DNMT3B) and miR 124-3pa expressions in bladder cancer tissues.
    Fawzy MS; El Faiomy ARM; El Desoky AMZ; Hussein S
    Mol Biol Rep; 2023 Dec; 50(12):10005-10013. PubMed ID: 37902910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNMT1-mediated NR3C1 DNA methylation enables transcription activation of connexin40 and augments angiogenesis during colorectal cancer progression.
    Zhai P; Zhang H; Li Q; Yang M; Guo Y; Xing C
    Gene; 2024 Jan; 892():147887. PubMed ID: 37813207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of microRNA-432-5p by DNA methyltransferase 3B leads to development of colorectal cancer through upregulation of CCND2.
    Yun Z; Yue M; Kang Z; Zhang P
    Exp Cell Res; 2022 Jan; 410(1):112936. PubMed ID: 34801563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression.
    Ibrahim AE; Arends MJ; Silva AL; Wyllie AH; Greger L; Ito Y; Vowler SL; Huang TH; Tavaré S; Murrell A; Brenton JD
    Gut; 2011 Apr; 60(4):499-508. PubMed ID: 21068132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.
    Ghoshal K; Motiwala T; Claus R; Yan P; Kutay H; Datta J; Majumder S; Bai S; Majumder A; Huang T; Plass C; Jacob ST
    PLoS One; 2010 Apr; 5(4):e10338. PubMed ID: 20454457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.
    Chen N; Zhao G; Yan X; Lv Z; Yin H; Zhang S; Song W; Li X; Li L; Du Z; Jia L; Zhou L; Li W; Hoffman AR; Hu JF; Cui J
    Genome Biol; 2018 Dec; 19(1):218. PubMed ID: 30537986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT3b affects colorectal cancer development by regulating FLI1 through DNA hypermethylation.
    Zhou L; Pan LZ; Fan YJ
    Kaohsiung J Med Sci; 2023 Apr; 39(4):364-376. PubMed ID: 36655868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?
    Tse JWT; Jenkins LJ; Chionh F; Mariadason JM
    Trends Cancer; 2017 Oct; 3(10):698-712. PubMed ID: 28958388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of Fli1 in autoimmune diseases.
    He YS; Yang XK; Hu YQ; Xiang K; Pan HF
    Int Immunopharmacol; 2021 Jan; 90():107127. PubMed ID: 33234418
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.